Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage biopharmaceutical company ...

Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three ...

The U.S. Food and Drug Administration has lifted a clinical hold on three cell therapies being developed by CARsgen ...

The Cebu Provincial Government has signed a memorandum of agreement with the Department of Science and Technology and the Food and Drugs Administration to improve the quality of products produced by ...

The GMP inspection, conducted by EMA representatives from April 8-12, 2024, assessed mammalian and microbial drug substance ...

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...

The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial ...

Pinnacle’s General Oral Solids facility in Baddi is a world-class manufacturing hub designed to meet and exceed global ...

Venus Remedies’ Baddi robotic pre-filled syringe facility receives Malaysian PIC/S GMP approval: Our Bureau, Mumbai Tuesday, November 5, 2024, 12:15 Hrs [IST] Venus Remedies Lim ...